Lyme disease vaccine (MedImmune)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLyme disease vaccine (MedImmune)
Drug Alias NamerBCG-OspA莱姆病疫苗（MedImmune）MEDI-490
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsLyme Disease

Other Information

ATC CodeN/A
Related LinksN/A